Search results

• 2023

  Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course

  Abdel-Mannan, O., Champsas, D., Tur, C., Lee, V., Manivannan, S., Usman, H., Skippen, A., Desai, I., Chitre, M., Forsyth, R., Kneen, R., Ram, D., Ramdas, S., Rossor, T., West, S., Wright, S., Palace, J., Wassmer, E., Hemingway, C., Lim, M. J., & 3 othersMankad, K., Ciccarelli, O. & Hacohen, Y., 18 Nov 2023, (E-pub ahead of print) In: Journal of Neurology, Neurosurgery and Psychiatry. jnnp-2023-332542.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Myelin-Oligodendrocyte Glycoprotein 100%
  • Pediatrics 44%
  • Antibodies 38%
  • Multiple Sclerosis 38%
  • Brain 33%

• Gross Motor Function in Pediatric Onset TUBB4A-Related Leukodystrophy: GMFM-88 Performance and Validation of GMFC-MLD in TUBB4A

  Gavazzi, F., Patel, V., Charsar, B., Glanzman, A., Erler, J., Sevagamoorthy, A., McKenzie, E., Kornafel, T., Ballance, E., Pierce, S. R., Teng, M., Formanowski, B., Woidill, S., Shults, J., Wassmer, E., Tonduti, D., Magrinelli, F., Bernard, G., Van Der Knaap, M., Wolf, N., & 2 othersAdang, L. & Vanderver, A., Aug 2023, In: Journal of Child Neurology. 38, 8-9, p. 498-504 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Metachromatic Leukodystrophy 100%
  • Pediatrics 42%
  • Movement Disorders 8%
  • Age of Onset 6%
  • Reproducibility of Results 6%
• 2022

  Clinical features, investigations, and outcomes of pediatric limbic encephalitis: A multicenter study

  Sabanathan, S., Abdel-Mannan, O., Mankad, K., Siddiqui, A., Das, K., Carr, L., Eltze, C., Eyre, M., Gadian, J., Hemingway, C., Kaliakatsos, M., Kneen, R., Krishnakumar, D., Lynch, B., Parida, A., Rossor, T., Taylor, M., Wassmer, E., Wright, S., Lim, M., & 1 othersHacohen, Y., Jan 2022, In: Annals of Clinical and Translational Neurology. 9, 1, p. 67-78 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Limbic Encephalitis 100%
  • Multicenter Studies 57%
  • Autoimmune limbic encephalitis 48%
  • Pediatrics 42%
  • Anti-Idiotypic Antibodies 33%

• Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom

  Satukijchai, C., Mariano, R., Messina, S., Sa, M., Woodhall, M. R., Robertson, N. P., Ming, L., Wassmer, E., Kneen, R., Huda, S., Jacob, A., Blain, C., Halfpenny, C., Hemingway, C., O'Sullivan, E., Hobart, J., Fisniku, L. K., Martin, R., Dopson, R., Cooper, S. A., & 5 othersWilliams, V., Waters, P. J., Ramdas, S., Leite, M. I. & Palace, J., 10 Jan 2022, In: JAMA Network Open. 5, 1, e2142780.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Myelin-Oligodendrocyte Glycoprotein 100%
  • Recurrence 39%
  • Acute Disseminated Encephalomyelitis 14%
  • Optic Neuritis 12%
  • Therapeutics 11%

• Incidence of paediatric multiple sclerosis and other acquired demyelinating syndromes: 10-year follow-up surveillance study

  Abdel-Mannan, O., Absoud, M., Benetou, C., Hickson, H., Hemingway, C., Lim, M., Wright, S., Hacohen, Y. & Wassmer, E., 1 Apr 2022, In: Developmental Medicine and Child Neurology. 64, 4, p. 502-508

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Pediatrics 72%
  • Incidence 55%
  • Child 49%
  • Acute Disseminated Encephalomyelitis 20%

• Isolated central nervous system familial hemophagocytic lymphohistiocytosis (fHLH) presenting as a mimic of demyelination in children

  Parida, A., Abdel-Mannan, O., Mankad, K., Foster, K., Ramdas, S., Ram, D., Eleftheriou, D., Hemingway, C., Hacohen, Y. & Wassmer, E., 1 Apr 2022, In: Multiple Sclerosis Journal. 28, 4, p. 669 - 675

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hemophagocytic Lymphohistiocytosis 100%
  • Demyelinating Diseases 79%
  • Central Nervous System 56%
  • Hematopoietic Stem Cell Transplantation 54%
  • Child 32%
• 2021

  Current international trends in the treatment of multiple sclerosis in children: impact of the COVID-19 pandemic

  Sandesjö, F., Wassmer, E., Deiva, K., Amato, M. P., Chitnis, T., Hemingway, C., Krupp, L., Pohl, D., Rostasy, K., Waubant, E., Banwell, B. & Wickström, R., Nov 2021, In: Multiple Sclerosis and Related Disorders. 56, 103277.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Pandemics 100%
  • Multiple Sclerosis 82%
  • Child 40%
  • Neurologists 34%
  • Pediatrics 33%
• 2019

  Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia

  Wassmer, E. & Maher, E. R., 2 May 2019, In: American Journal of Human Genetics. 104, 5, p. 948-956 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hyperkinesis 100%
  • Loss of Heterozygosity 82%
  • Loss of Function Mutation 80%
  • Dyskinesias 78%
  • Brain Diseases 67%
• 2009

  Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia

  Kurian, M. A., Zhen, J., Cheng, S-Y., Li, Y., Mordekar, S. R., Jardine, P., Morgan, N. V., Meyer, E., Tee, L., Pasha, S., Wassmer, E., Heales, S. J. R., Gissen, P., Reith, M. E. A. & Maher, E. R., 26 May 2009, In: Journal of Clinical Investigation. 119, 6, p. 1595-603 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Infantile Parkinsonism-Dystonia 100%
  • Dopamine Plasma Membrane Transport Proteins 54%
  • Loss of Function Mutation 49%
  • Movement Disorders 32%
  • Dopamine 24%